Posted innews Psychiatry Public Health
Health Plan Disenrollment and Mortality After Starting Medications for Opioid Use Disorder
A large cohort study found that health plan disenrollment after starting buprenorphine or naltrexone for opioid use disorder was linked to higher all-cause and overdose mortality, highlighting the importance of continuous coverage and treatment access.